https://www.selleckchem.com/products/ha130.html
7% maintained virological suppression. Virological failure (VF) was observed in 6 patients (1.8%). Adverse event (AE)-related discontinuations were 4.5%. After 48 weeks, we found a significant improvement in both triglycerides (median, 130.0 mg/dL to 113.5 mg/dL, p=0.0254) and HDL cholesterol (48 to 49 mg/dL, p less then 0.0001) but no change in other biomarkers. DRV trough concentrations in 56 subjects showed a median value of 2862.5 (1469.5-4439. ng/mL, higher in females than in males (4221 ng/mL vs. 2634 ng/mL, p=0.046). CONCLUSIONS
Like
Comment
Share
